Human pluripotent stem cell-derived atrioventricular node-like pacemaker cells exhibit biological conduction bridge properties in vitro and in vivo
Michelle Lohbihler, Amos A. Lim, Stéphane MasséiD, Maggie Kwan, Omar MouradiD, Olya Mastikhina, Brandon M. MurareanuiD, Malak ElbatarnyiD, Renu Sarao, Beiping QiangiD, Wahiba Dhahri, Matthew L. ChangiD, Alice L.Y. Xu, Amine MazineiD, Shahryar KhattakiD, Sara Santana NunesiD, Kumaraswamy NanthakumariD, Michael A. LaflammeiD, Stephanie I. ProtzeiD
Abstract
The atrioventricular node (AVN) ensures synchronized heart contractions by establishing the electrical connection between the atria and ventricles. Dysfunction of the pacemaker cells of the AVN leads to atrioventricular block (AV block), a life-threatening condition managed with electronic pacemakers (EPMs). EPMs have drawbacks that could be overcome by a human pluripotent stem cell (hPSC)-derived biological conduction bridge (BioCB). Recent studies demonstrated the differentiation of AVN-like cells from hPSCs, but their conduction properties upon engraftment in vivo remain unexplored. Here we report the generation of AVN-like pacemaker cells (AVNLPCs) from hPSCs using WNT and BMP signaling modulation. These AVNLPCs transcriptionally resemble fetal AVN pacemaker cells, exhibit pacemaker action potentials, and display unique AVN-like conduction properties. Notably, when transplanted into the guinea pig heart, AVNLPCs replicate the functional properties of the AVN. Our study highlights the potential of an AVNLPC-based BioCB as novel cell therapy to improve treatment for AV block patients.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cellular Heterogeneity of Pluripotent Stem Cell Derived Cardiomyocyte Grafts is Mechanistically Linked to Treatable Arrhythmias
D. Selvakumar, Z. E. Clayton, … J. J. H. Chong·bioRxiv·Sep 15, 2022
- Bradycardic mice undergo effective heart rate improvement after specific homing to the sino-atrial node and differentiation of adult muscle derived stem cells.
P. Mesirca, D. Mamaeva, … A. Fernandez·bioRxiv·Apr 7, 2020
- Pharmacologic Therapy for Engraftment Arrhythmia Induced by Transplantation of Human Cardiomyocytes
K. Nakamura, L. E. Neidig, … C. E. Murry·Stem Cell ReportsPeer-reviewed·Oct 1, 2021
- Human iPSC-derived Committed Cardiac Progenitors Generate Cardiac Tissue Grafts in a Swine Ischemic Cardiomyopathy Model without Triggering Ventricular Arrhythmias
Amish N. Raval, Eric G. Schmuck, … Timothy J. Kamp·Journal of the American Heart AssociationPeer-reviewed·Jul 25, 2026
- Impulse initiation in engrafted pluripotent stem cell-derived cardiomyocytes can stimulate the recipient heart.
T. Stuedemann, B. Schwarzova, … F. Weinberger·Stem Cell ReportsPeer-reviewed·Aug 1, 2024
- AAV6-HCN4t-mediated biological pacing as a potential life-saving therapy for congenital complete heart block
Jianan Wang, Evelien E. Birza, … Gerard J.J. Boink·bioRxiv·Jul 31, 2025